About LynxCare
Unlock Insights in Multiple Myeloma
LynxCare's vast and validated datasets offers fresh insights into Multiple Myeloma (MM), including comorbidity factors, treatment patterns, and staging. With over +585 estimated patients and 348 endpoints measured, our granular and quality-controlled real world dataset can unlock invaluable insights into the treatment and prognosis of MM, empowering clinicians to make informed decisions.
LynxCare's vast and validated Multiple Myeloma datasets* can support you to push your research studies forward with the level of quality necessary to help improve the patient journey, offering fresh insights into Multiple Myeloma, including comorbidity factors, treatment patterns, and staging.
Dive deeper into understanding the data sources, the dataset's representativeness, the significance of unstructured data, and what sets LynxCare's dataset apart from competitors.
➡ CLICK HERE
* LynxCare datasets concern datasets within the LynxCare hospital network. The hospitals are the data controllers. No commitment before site approval on RWE request.
.png)
